Top investment banker Marcus Schenck, a contender to run Deutsche Bank AG until his departure in a shakeup this year, is charting a comeback at Perella Weinberg Partners LP, an underdog in European deals.
He stepped down as Deutsche Bank’s deputy chief executive officer and head of its investment bank in April as then-CEO John Cryan left. At the time, Schenck was said to have disagreed with the bank’s direction.
In the meantime, Bloomberg also reports that JPMorgan Chase is in talks to rehire Ling Zhang from Chinese DNA sequencing giant BGI Genomics Co., as it seeks to strengthen its Asia health-care deals coverage after a senior departure this year, people familiar with the matter said.
Zhang is expected to start working on the bank’s health-care investment banking team in Hong Kong early next year, the people said, who asked not to be identified because details are private. He briefly worked at JPMorgan before joining BGI as chief operating officer in 2015.